Pulmokine is the top competitor of RareGen. Pulmokine is headquartered in Rensselaer, New York, and was founded in 2007. Pulmokine competes in the Pharmaceuticals field. Pulmokine generates 30% the revenue of RareGen.

Amicus is perceived as one of RareGen's biggest rivals. Amicus was founded in Philadelphia, Pennsylvania} in 2002. Like RareGen, Amicus also operates in the Pharmaceuticals industry. Compared to RareGen, Amicus generates $224.6M more revenue.

Ultragenyx is seen as one of RareGen's top competitors. Ultragenyx is a Public company that was founded in Novato, California in 2010. Like RareGen, Ultragenyx also works within the Pharmaceuticals industry. Ultragenyx has 859 more employees vs. RareGen.